IP Library Granted Patent US 9,670,484
Granted Patent B2
US 9,670,484 · App. 14/339,327 · Granted Jun 6, 2017

Methods and compositions

Inventors: Gregory Paul Winter (Cambridge, GB); Christian Heinis (Bern, CH)
Assignee: BICYCLE THERAPEUTICS LIMITED
C12N15/1062A61K47/481A61K47/48023A61K47/48246C07K1/1075C07K1/1077C07K14/005C12N15/1037C12N15/1041C12N15/1068C40B40/08C40B50/06G01N33/56983C40B40/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,670,484
App. No.
14/339,327
Granted
Jun 6, 2017
Kind
B2
Abstract

The invention relates to a complex comprising a phage particle, said phage particle comprising (i) a polypeptide; (ii) a nucleic acid encoding the polypeptide of (i); (iii) a connector compound attached to said polypeptide wherein said connector compound is attached to the polypeptide by at least three discrete covalent bonds. The invention also relates to libraries, and to methods for making complexes and to methods of screening using same.

Claims (6)

1. A genetically encoded polypeptide library of complexes comprising:

(a) a nucleic acid genetically encoding a polypeptide of the polypeptide library;

(b) the genetically encoded polypeptide library displayed on a phage display system, wherein the polypeptide comprises the sequence (X)IC(X)mC(X)nC(X)o (SEQ ID No. 67), wherein C represents the amino acid cysteine, X represents a random amino acid, m and n are numbers between 1 and 20 defining the length of intervening polypeptide segments and I and o are numbers between 0 and 20 defining the length of the flanking polypeptide segments;

(c) the polypeptide encoded by the nucleic acid is linked to the nucleic acid by the phage; and

(d) the polypeptides in the polypeptide library are attached to tris-(bromomethyl)benzene (TBMB) by three discrete covalent bonds between said TBMB and said polypeptide via said C amino acid residues, and form at least one loop which comprises a sequence of two or more amino acids subtended between two of said C amino acid residues, thus forming the one or more peptide ligand.

2. The genetically encoded polypeptide library of complexes of claim 1 , wherein the polypeptide comprises a sequence SEQ ID No. 1-5, 9, 10, or 36-63.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2025
From: WINTER, GREGORY PAUL; HEINIS, CHRISTIAN
To: BICYCLE THERAPEUTICS LIMITED
Reel/Frame 070539/0133 →
CHANGE OF NAME Recorded Feb 12, 2018
From: BICYCLE THERAPEUTICS LIMITED
To: BICYCLERD LIMITED
Reel/Frame 044905/0516 →
Priority Claims (2)
GB 0802079.4 · Feb 5, 2008 · national
GB 0818399.8 · Oct 8, 2008 · national
Continuity (3)
Continuation 13973297 · Aug 22, 2013
Division 12866214
Related Publication 20150166988A1 · Jun 18, 2015